Mary Fisher
About Mary Fisher
Mary Fisher serves as the Chair and Chief Executive Officer of Colorescience and has been a Director at Dermata Therapeutics, Inc. since 2021. She has a notable history in the pharmaceutical industry, including leading the sale of SkinMedica to Allergan for $375 million and holding various executive positions at multiple companies.
Work at Colorescience
Mary Fisher has served as Chair and Chief Executive Officer of Colorescience since 2013. Under her leadership, the company has focused on developing innovative skincare products that combine cosmetic benefits with sun protection. Fisher's extensive experience in the dermatology and pharmaceutical sectors has contributed to Colorescience's growth and market presence.
Current Role at Dermata Therapeutics
Since 2021, Mary Fisher has held the position of Director at Dermata Therapeutics, Inc. In this role, she contributes to the strategic direction of the company, which specializes in developing innovative therapies for dermatological conditions. Her background in commercialization and operations enhances the company's efforts in bringing effective treatments to market.
Professional Background
Mary Fisher has a diverse professional background in the pharmaceutical and biotechnology industries. She worked at Cephalon as Vice President of Commercial Operations and Strategic Healthcare from 1994 to 1999. Following that, she served as Chief Operating Officer at Acorda Therapeutics from 2000 to 2007, where she played a significant role in transitioning the company to a commercial stage operation.
Achievements in Leadership
Mary Fisher led the successful sale of SkinMedica to Allergan, Inc. for $375 million. She was also recognized as Ernst & Young's Entrepreneur of the Year for San Diego, California, and named a finalist for Most Admired CEO by the San Diego Business Journal. Additionally, she received the EY Venture Capital Award of Excellence for her contributions to the industry.
Memberships and Board Positions
Mary Fisher is an active member of the Women’s Dermatological Society and the Dermatology Foundation Leader’s Society. She serves on the board of directors for Sientra and Dermata Therapeutics, and is a board member of Zeltiq and OvaScience. Her involvement in these organizations reflects her commitment to advancing dermatological care and supporting women in leadership roles within the industry.